DNA blood test may personalize esophageal cancer therapy
NCT ID NCT06792786
First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study looks at whether tracking tumor DNA in the blood (ctDNA) can help doctors decide the best treatment for people with advanced esophageal cancer. About 30 participants will receive a combination of immunotherapy and chemotherapy, followed by radiation and chemo. The goal is to see if ctDNA changes can predict how well the treatment works and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinhua Municipal Central Hospital
RECRUITINGJinhua, Zhejiang, 321000, China
-
The central Hospital of Lishui City
RECRUITINGLishui, Zhejiang, 323000, China
Conditions
Explore the condition pages connected to this study.